BACKGROUND: Fascin is overexpressed in many cancers, including colorectal, but its role in the malignant transformation of benign colorectal adenomas is unclear. METHODS: Immunohistochemical analysis of fascin expression was carried out in resected human colorectal adenoma specimens. The effects of forced overexpression of fascin on adenoma cell motility were also analysed. RESULTS: We show fascin overexpression in adenomas increasing with tumour size, histological type, and degree of dysplasia and increased cell motility in adenoma cell lines following fascin transfection. CONCLUSION: These data suggest an important role for fascin in the malignant progression of colorectal tumours. Colorectal cancer development is widely accepted to involve the multifaceted progression of a benign lesion (adenoma) to invasive adenocarcinoma (hereafter referred to as 'carcinoma') by acquisition of a migratory, and ultimately invasive phenotype (Muto et al, 1975). The precise nature of the changes required for the malignant progression of adenomas remain poorly understood but prognosis is widely accepted to correlate with both the physical size and histological type of the adenomatous polyp, as well as the degree of cellular dysplasia displayed by the tumour cells (Muto et al, 1975).The changes in motile behaviour demonstrated by tumour cells require dynamic rearrangements in the actin cytoskeleton, which are governed by multiple actin-binding proteins (Matsudaira, 1994). The 55 kDa fascin-1 protein (hereafter be referred to simply as fascin) localises to the core actin bundles of spikes and filopodia at the leading edge of migratory cells, and has been shown to increase migration in several cell types (Adams, 2001;Kureishy et al, 2002). There now exists a plethora of reports showing a general trend across epithelial tissues with fascin being absent from normal epithelium and present in tumours of the same tissue origin (Hashimoto et al, 2005).We have previously shown that fascin is absent from normal colorectal epithelium but overexpressed in colorectal carcinomas (Sawhari et al, 2003). Two recent studies have demonstrated that fascin expression correlates with a poor prognosis in colorectal cancers (Hashimoto et al, 2006;Puppa et al, 2007). Hashimoto et al. (2006) found no correlation between the genetic origin of colorectal adenomas (FAP or sporadic) and fascin expression (Hashimoto et al, 2006). However, to date, no study has been reported analysing the expression and distribution of fascin in benign colorectal adenomas in relation to the clinical risk factors associated with malignant tumour progression.To understand the role of a gene during tumourigenesis, it is important to know at what stage it becomes deregulated. In the study presented here, we sought to determine this potential relationship between fascin expression and malignant progression in colorectal adenomas. We performed immunohistochemistry for fascin on colorectal adenoma specimens graded for the risk factors associated with malignant potential, namely pol...